GPC3-CAR-T cells

glypican-3-targeted chimeric antigen receptor T cells · Second Affiliated Hospital of Guangzhou Medical University

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GPC3-CAR-T cells, covering 2016-03-22 to 2024-06-25. Get the full timeline:

Most recent: Clinical Trial Update: GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression [Phase 1]